JP Morgan

Pfizer moves forward with once-daily weight-loss pill

Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice- daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under development by companies including Eli Lilly and Novo Nordisk that will offer patients a more convenient alternative to injections. Some analysts expect the weight-loss drug market, currently dominated ...

June 10, 2024 3:46 PM

Euro and French markets roiled by shock Macron election call

The euro tumbled, while French bonds and stocks were hit hard on Monday, following French President Emmanuel Macron's decision to call a snap parliamentary election after being trounced in a European Union vote by the far right. The euro fell 0.5% to a one-month low of $1.0764 and slumped to a 21-month trough against sterling of 84.53 pence. French blue-chip stocks dropped 2%, led by steep losses in the likes of lenders such as BNP Paribas and Societe Generale, making the CAC 40 the worst-...